139 related articles for article (PubMed ID: 3566254)
1. In vitro susceptibility of Capnocytophaga species to antimicrobial agents.
Hawkey PM; Smith SD; Haynes J; Malnick H; Forlenza SW
Antimicrob Agents Chemother; 1987 Feb; 31(2):331-2. PubMed ID: 3566254
[TBL] [Abstract][Full Text] [Related]
2. In vitro susceptibility of Capnocytophaga species to 29 antimicrobial agents.
Rummens JL; Gordts B; Van Landuyt HW
Antimicrob Agents Chemother; 1986 Nov; 30(5):739-42. PubMed ID: 3800350
[TBL] [Abstract][Full Text] [Related]
3. In vitro susceptibility of Capnocytophaga strains to 18 antimicrobial agents.
Sutter VL; Pyeatt D; Kwok YY
Antimicrob Agents Chemother; 1981 Aug; 20(2):270-1. PubMed ID: 7283424
[TBL] [Abstract][Full Text] [Related]
4. Susceptibility testing of Danish isolates of Capnocytophaga and CDC group DF-2 bacteria.
Bremmelgaard A; Pers C; Kristiansen JE; Korner B; Heltberg O; Frederiksen W
APMIS; 1989 Jan; 97(1):43-8. PubMed ID: 2914105
[TBL] [Abstract][Full Text] [Related]
5. In vitro susceptibility of 96 Capnocytophaga strains, including a beta-lactamase producer, to new beta-lactam antibiotics and six quinolones.
Arlet G; Sanson-Le Pors MJ; Casin IM; Ortenberg M; Perol Y
Antimicrob Agents Chemother; 1987 Aug; 31(8):1283-4. PubMed ID: 3498438
[TBL] [Abstract][Full Text] [Related]
6. Susceptibility of Capnocytophaga to antimicrobial agents.
Kolokotronis A
J Chemother; 1995 Oct; 7(5):414-6. PubMed ID: 8596122
[TBL] [Abstract][Full Text] [Related]
7. Antimicrobial susceptibilities and beta-lactamase characterization of Capnocytophaga species.
Roscoe DL; Zemcov SJ; Thornber D; Wise R; Clarke AM
Antimicrob Agents Chemother; 1992 Oct; 36(10):2197-200. PubMed ID: 1444299
[TBL] [Abstract][Full Text] [Related]
8. Antimicrobial susceptibility of Bacillus anthracis.
Doğanay M; Aydin N
Scand J Infect Dis; 1991; 23(3):333-5. PubMed ID: 1909051
[TBL] [Abstract][Full Text] [Related]
9. Capnocytophaga.
Sinnott JT; Cullison JP; Blanco PJ
Infect Control Hosp Epidemiol; 1988 Apr; 9(4):170-3. PubMed ID: 3361109
[TBL] [Abstract][Full Text] [Related]
10. Selective recovery of oral Capnocytophaga spp. with sheep blood agar containing bacitracin and polymyxin B.
Mashimo PA; Yamamoto Y; Nakamura M; Slots J
J Clin Microbiol; 1983 Feb; 17(2):187-91. PubMed ID: 6833474
[TBL] [Abstract][Full Text] [Related]
11. Quality control limits for microdilution susceptibility tests with aztreonam, imipenem, ceftriaxone, ceftazidime, ceftizoxime, cefuroxime, and cefonicid.
Barry AL; Gavan TL; Jones RN; Ayers LW; Fuchs PC; Gerlach EH; Thornsberry C
Diagn Microbiol Infect Dis; 1987 May; 7(1):83-7. PubMed ID: 3121242
[TBL] [Abstract][Full Text] [Related]
12. Role of DNA gyrase and topoisomerase IV mutations in fluoroquinolone resistance of Capnocytophaga spp. clinical isolates and laboratory mutants.
Ehrmann E; Jolivet-Gougeon A; Bonnaure-Mallet M; Fosse T
J Antimicrob Chemother; 2017 Aug; 72(8):2208-2212. PubMed ID: 28453633
[TBL] [Abstract][Full Text] [Related]
13. Antimicrobial susceptibility of Capnocytophaga spp.
Verghese A; Franzus B; Berk S; Roscoe DL; Clarke AM
Antimicrob Agents Chemother; 1993 May; 37(5):1206. PubMed ID: 8517718
[No Abstract] [Full Text] [Related]
14. Antibiotic susceptibility of blood and cerebrospinal fluid isolates of Haemophilus influenzae.
Bannatyne RM; Toma S; Cheung R; Hodge D
J Antimicrob Chemother; 1985 Feb; 15(2):187-91. PubMed ID: 3872296
[TBL] [Abstract][Full Text] [Related]
15. Bacteremia by multidrug-resistant Capnocytophaga sputigena.
Gomez-Garces JL; Alos JI; Sanchez J; Cogollos R
J Clin Microbiol; 1994 Apr; 32(4):1067-9. PubMed ID: 8027314
[TBL] [Abstract][Full Text] [Related]
16. In vitro susceptibilities of Capnocytophaga isolates to beta-lactam antibiotics and beta-lactamase inhibitors.
Jolivet-Gougeon A; Buffet A; Dupuy C; Sixou JL; Bonnaure-Mallet M; David S; Cormier M
Antimicrob Agents Chemother; 2000 Nov; 44(11):3186-8. PubMed ID: 11036049
[TBL] [Abstract][Full Text] [Related]
17. Analysis of Salmonella spp. with resistance to extended-spectrum cephalosporins and fluoroquinolones isolated in North America and Latin America: report from the SENTRY Antimicrobial Surveillance Program (1997-2004).
Biedenbach DJ; Toleman M; Walsh TR; Jones RN
Diagn Microbiol Infect Dis; 2006 Jan; 54(1):13-21. PubMed ID: 16290025
[TBL] [Abstract][Full Text] [Related]
18. In vitro susceptibility of Alcaligenes denitrificans subsp. xylosoxidans to 24 antimicrobial agents.
Glupczynski Y; Hansen W; Freney J; Yourassowsky E
Antimicrob Agents Chemother; 1988 Feb; 32(2):276-8. PubMed ID: 3163242
[TBL] [Abstract][Full Text] [Related]
19. Gram-negative bacilli resistant to third-generation cephalosporins: beta-lactamase characterization and susceptibility to Sch 34343.
Medeiros AA; Hare R; Papa E; Adam C; Miller GH
J Antimicrob Chemother; 1985 Jun; 15 Suppl C():119-32. PubMed ID: 3875602
[TBL] [Abstract][Full Text] [Related]
20. [The prevalence and antibiotic susceptibility of Capnocytophaga and Actinobacillus actinomycetemcomitans in the periodontal pockets of periodontitis patients with insulin-independent diabetes mellitus].
Son SH; Choi SM; Han SB; Chung CP
Taehan Chikkwa Uisa Hyophoe Chi; 1986 Nov; 24(11):961-8. PubMed ID: 3474309
[No Abstract] [Full Text] [Related]
[Next] [New Search]
